Wolfgang Gehring

发表

Final Analysis of DeCOG-SLT Trial: No Survival Benefit for Complete Lymph Node Dissection in Patients With Melanoma With Positive Sentinel Node.

C. Berking, C. Garbe, W. Hohenberger, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial.

C. Berking, C. Garbe, W. Hohenberger, 2016, The Lancet. Oncology.

Survival of SLNB-positive melanoma patients with and without complete lymph node dissection: A multicenter, randomized DECOG trial.

C. Berking, C. Garbe, W. Hohenberger, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Final analysis of DECOG-SLT trial: Survival outcomes of complete lymph node dissection in melanoma patients with positive sentinel node.

C. Berking, C. Garbe, W. Hohenberger, 2018 .